Stay updated on Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new site-wide notice has been added about the lapse in government funding and the NIH Clinical Center's operating status. The page revision has been updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T06:21:55.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now shows a glossary toggle and includes updated Study Record Dates such as Results First Posted and Certification/Extension First Posted, along with a new Revision/Version label.
    Difference
    0.3%
    Check dated 2026-01-28T04:24:11.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Results posted for PICCOLO (NCT05041257): the page now includes posted results and related details for the Phase 2, single-arm Mirvetuximab Soravtansine study in FRα-positive ovarian, peritoneal, and fallopian tube cancers. The locations list has been updated to 35 sites worldwide with corresponding names and IDs, and key identifiers (EudraCT 2021-003592-34) plus study start and completion dates are displayed.
    Difference
    9%
    Check dated 2026-01-14T02:41:59.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The Locations section was expanded to include numerous US states and international sites (e.g., New South Wales, South Australia, Victoria, Ontario, Quebec, Madrid), while the HHS Vulnerability Disclosure link was removed.
    Difference
    2%
    Check dated 2025-12-23T13:31:27.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The study record shows a status change from 'No Results Posted' to 'Results Submitted' for NCT05041257.
    Difference
    0.0%
    Check dated 2025-12-09T00:25:57.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.1 to v3.3.2 on the page; no substantive study information or user-facing features are affected.
    Difference
    0.0%
    Check dated 2025-12-01T17:31:20.000Z thumbnail image

Stay in the know with updates to Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.